No vaccination, No benefits, says Australian PM
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Apr, 2015
Singapore: Australian government has recently made an announcement that parents who refuse to vaccinate their children m...Read more
Vaxxas' Nanopatch is the future of needle-free vaccine
Australia | Influencers | By Piyusha Chatterjee | 2 Comment | 17 Oct, 2012
One of the challenges in the R&D of next generation vaccines is the development of a delivery technology that will b...Read more
The unconventional side of vaccines
Australia | Opinion | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2012
When we talk about vaccines, most people think of an injection to prevent childhood infectious disease. However, in rece...Read more
Viralytics melanoma trial meets primary endpoint
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013
Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...Read more
QRxPharma, Paladin sign $25.5 mn morphine deal
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Oct, 2012
Singapore: Australia's QRxPharma has collaborated with Canadian specialty pharmaceutical company, Paladin Labs on licens...Read more
BioAsia 2014: Innovation, collaboration identified as success keys
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2014
Hyderabad: With emphasis on cutting-edge innovations this year, BioAsia 2014 under the theme 'Innovate. Evolve.' kick-st...Read more
Gilead commercial operations head to retire
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2014
Singapore: Gilead Sciences' head of commercial operations for the past decade, Mr Kevin Young, who oversaw tremendous sa...Read more
Ebola: Australia pledges $17m for treatment centre
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Nov, 2014
Singapore: Australian Prime Minister Mr Tony Abbott said that the nation is contracting a private company to staff and o...Read more
URMC launches new heart device trial in Asia
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2013
Singapore: Cardiologists at the University of Rochester Medical Center, US, are launching a new study in an effort to im...Read more
Viralytics' new CAVATEK study to be held in the UK
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2012
Singapore: The next Viralytics clinical study evaluating multi doses of CAVATAK administered by the intravenous route ...Read more
FDA doesn't approve Pharmaxis' Bronchitol
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 20 Mar, 2013
Singapore: Pharmaxis received a complete response letter from the US FDA confirming that Bronchitol cannot yet be appro...Read more
APAC coronary stent sector to touch $1.5 bn in 2015
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 09 Apr, 2015
Singapore: Asia-Pacific, including Japan, China, India, New Zealand, South Korea and Australia, is the fastest growing r...Read more
Track the walk: a fall-proof method
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 22 Nov, 2014
Singapore: CDC predicts that every year, one in every three adults in the age group of 65 or older falls and around 2 mi...Read more
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 05 Nov, 2013
Industry forecasts by market analysts state that 80 percent of the multinational companies expect to gain a good share i...Read more
Biochips market to be worth $11.4 bn by 2018
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
Singapore: A recent report released by RnRMarketResearch.com has analyzed the Global Biochips Industry and forecasted th...Read more
Physicians, consumers lack trust in Aus healthcare
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 13 Feb, 2013
Singapore: Australia boasts an advanced healthcare system supported by both the public and private sector involvement. T...Read more
EMA gives Patrys cancer drug orphan status
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Sep, 2013
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted orphan drug designation by t...Read more
Novogen drug candidate effective as anti-cancer agent in preclinical studies
Australia | News | By BioSpectrum Bureau | 0 Comment | 14 May, 2015
Singapore: US-Australian drug discovery company, Novogen's drug candidate, Anisina, has progressed successfully in pre-c...Read more